|
| ALDH2*1/*1 (n = 15) | ALDH2*1/*2 (n = 16) | p by Student’s t-test (*1/*1 vs *1/*2) | |
| GGT (U/l) | DT1 | 21.8 (11.2)a,b | 20.7 (7.3) | 0.743 |
| DT2 | 23.7 (12.4)b | 23.3 (12.4) | 0.923 | |
| DT3 | 20.2 (9.0)a | 21.8 (10.2) | 0.644 | |
| p by repeated ANOVA | 0.010 | 0.110 |
| |
| Uric acid (mg/dl) | DT1 | 5.8 (1.1)a | 5.7 (0.9) | 0.771 |
| DT2 | 6.3 (1.1)b | 5.9 (1.1) | 0.261 | |
| DT3 | 5.6 (0.9)a | 5.8 (0.9) | 0.677 | |
| p by repeated ANOVA | < 0.001 | 0.407 |
| |
| Triglyceride (mg/dl) | DT1 | 66.5 (27.6) | 71.1 (22.3) | 0.608 |
| DT2 | 62.4 (21.5) | 73.9 (28.1) | 0.211 | |
| DT3 | 67.3 (50.6) | 85.1 (49.3) | 0.328 | |
| p by repeated ANOVA | 0.811 | 0.292 |
| |
| LDL-cholesterol (mg/dl) | DT1 | 101.7 (24.1)a | 95.8 (21.4) | 0.474 |
| DT2 | 90.0 (21.6)b | 96.3 (26.9) | 0.479 | |
| DT3 | 90.3 (20.7)b | 98.7 (25.1) | 0.318 | |
| p by repeated ANOVA | 0.009 | 0.610 |
| |
| Total-cholesterol (mg/dl) | DT1 | 181.3 (23.2)a | 167.5 (21.3) | 0.096 |
| DT2 | 169.5 (20.5)b | 169.1 (23.9) | 0.954 | |
| DT3 | 168.1 (24.0)b | 169.7 (24.2) | 0.853 | |
| p by repeated ANOVA | 0.010 | 0.787 |
| |
| HDL-cholesterol (mg/dl) | DT1 | 61.3 (13.8) | 54.4 (6.5)a | 0.082 |
| DT2 | 63.5 (12.9) | 57.8 (6.0)b | 0.121 | |
| DT3 | 60.6 (15.1) | 53.3 (5.2)a | 0.104 | |
| p by repeated ANOVA | 0.275 | 0.002 |
| |
| Atherogenic index ((TC − HDL-C)/HDL-C) | DT1 | 2.1 (0.8)a | 2.1 (0.5)a,b | 0.897 |
| DT2 | 1.8 (0.7)b | 2.0 (0.6)a | 0.379 | |
| DT3 | 1.9 (0.8)a,b | 2.2 (0.6)b | 0.245 | |
| p by repeated ANOVA | 0.001 | 0.012 |
| |